Terms: = Colorectal cancer AND CSF3R, CD114, 1441, ENSG00000119535, GCSFR AND Prognosis
6 results:
1. G-CSF Is a Novel Mediator of T-Cell Suppression and an Immunotherapeutic Target for Women with Colon cancer.
Ray AL; Saunders AS; Nofchissey RA; Reidy MA; Kamal M; Lerner MR; Fung KM; Lang ML; Hanson JA; Guo S; Urdaneta-Perez MG; Lewis SE; Cloyde M; Morris KT
Clin Cancer Res; 2023 Jun; 29(11):2158-2169. PubMed ID: 36951682
[TBL] [Abstract] [Full Text] [Related]
2. The Impact of Serum Parameters Associated with Kidney Function on the Short-Term Outcomes and prognosis of colorectal cancer Patients Undergoing Radical Surgery.
Zhang B; Liu XR; Liu XY; Kang B; Yuan C; Liu F; Li ZW; Wei ZQ; Peng D
Can J Gastroenterol Hepatol; 2023; 2023():2017171. PubMed ID: 36890805
[TBL] [Abstract] [Full Text] [Related]
3. G-CSF in tumors: Aggressiveness, tumor microenvironment and immune cell regulation.
Karagiannidis I; Salataj E; Said Abu Egal E; Beswick EJ
Cytokine; 2021 Jun; 142():155479. PubMed ID: 33677228
[TBL] [Abstract] [Full Text] [Related]
4. Colony-stimulating factor 3 signaling in colon and rectal cancers: Immune response and CMS classification in TCGA data.
Saunders AS; Bender DE; Ray AL; Wu X; Morris KT
PLoS One; 2021; 16(2):e0247233. PubMed ID: 33606788
[TBL] [Abstract] [Full Text] [Related]
5. The prognostic value of TP53 and its correlation with EGFR mutation in advanced non-small cell lung cancer, an analysis based on cBioPortal data base.
Jiao XD; Qin BD; You P; Cai J; Zang YS
Lung Cancer; 2018 Sep; 123():70-75. PubMed ID: 30089598
[TBL] [Abstract] [Full Text] [Related]
6. The prognostic significance of UCA1 for predicting clinical outcome in patients with digestive system malignancies.
Liu FT; Dong Q; Gao H; Zhu ZM
Oncotarget; 2017 Jun; 8(25):40620-40632. PubMed ID: 28380443
[TBL] [Abstract] [Full Text] [Related]
